|
- Antimicrobial resistance - World Health Organization (WHO)
Antimicrobial resistance (AMR) threatens the effective prevention and treatment of an ever-increasing range of infections caused by bacteria, parasites, viruses and fungi AMR occurs when bacteria, viruses, fungi and parasites change over time and no longer respond to medicines making infections harder to treat and increasing the risk of
- Antimicrobial resistance - World Health Organization (WHO)
Antimicrobial resistance is the broader term for resistance in different types of microorganisms and encompasses resistance to antibacterial, antiviral, antiparasitic and antifungal drugs Antimicrobial resistance occurs naturally but is facilitated by the inappropriate use of medicines, for example using antibiotics for viral infections such
- WHO publishes the WHO Medically Important Antimicrobials List for Human . . .
The WHO list of medically important antimicrobials for human medicine (WHO MIA List) is a risk management tool that can be used to support decision-making to minimize the impact of antimicrobial use in non-human sectors on antimicrobial resistance (AMR) in humans The WHO MIA List is created to guide international, national, and subnational
- Antimicrobial resistance - World Health Organization (WHO)
Antimicrobial resistance refers to microorganisms no longer responding to antimicrobial medicine such as antibiotics This is a natural phenomenon that occurs over time through genetic changes in the microorganisms AMR is strongly accelerated by inappropriate use of antimicrobial medicine
- Strengthening antimicrobial resistance national action plans through . . .
As part of the 79th United Nations General Assembly (UNGA), global leaders convened for the second High-Level Meeting on Antimicrobial Resistance (AMR) The leaders approved a political declaration with clear targets and actions, including a 10% reduction in human deaths related to bacterial AMR – estimated at 4 95 million annually – by 2030
- Optimizing use of antimicrobial medicines - World Health Organization (WHO)
Overuse and misuse of antimicrobials are main drivers of antimicrobial resistance Since antimicrobials are a precious resource, it is essential that they are only prescribed by qualified healthcare professionals for patients with a confirmed need For all those patients, high-quality antimicrobials need to be accessible at any time to guarantee an appropriate clinical management To address
- Global research agenda for antimicrobial resistance in human health
The research agenda is global in scope and focuses on antimicrobial resistance in the human health sector, especially infections caused by the WHO bacterial priority pathogens and WHO fungal priority pathogens with critical importance for antimicrobial resistance (such as Candida auris, Aspergillus fumigatus and Cryptococcus neoformans), and drug-resistant Mycobacterium tuberculosis
- Antimicrobial resistance - World Health Organization (WHO)
What is antimicrobial resistance? Antimicrobial resistance is the ability of a microorganism (like bacteria, viruses, and some parasites) to stop an antimicrobial (such as antibiotics, antivirals and antimalarials) from working against it As a result, standard treatments become ineffective, infections persist and may spread to others
|
|
|